0001104659-23-006295.txt : 20230124
0001104659-23-006295.hdr.sgml : 20230124
20230124200438
ACCESSION NUMBER: 0001104659-23-006295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230120
FILED AS OF DATE: 20230124
DATE AS OF CHANGE: 20230124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neill Vincent
CENTRAL INDEX KEY: 0001672718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38410
FILM NUMBER: 23549450
MAIL ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001720893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821386754
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-643-8060
MAIL ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
tm232491-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-20
0
0001720893
BioXcel Therapeutics, Inc.
BTAI
0001672718
O'Neill Vincent
C/O BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, 12TH FLOOR
NEW HAVEN
CT
06511
0
1
0
0
Chief Medical Officer
Common Stock
2023-01-20
4
M
0
29713
0.41
A
29713
D
Common Stock
2023-01-20
4
S
0
29713
30.00
D
0
D
Employee Stock Option (right to buy)
0.41
2023-01-20
4
M
0
29713
0
D
2027-08-23
Common Stock
29713
29712
D
The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1.
The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $30.00 to $30.05. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
The options are fully vested and exercisable.
/s/ Richard I. Steinhart, as Attorney-in-Fact for Vincent O'Neill
2023-01-24